Randomized clinical trial shows propofol benefits nausea and vomiting in cesarean patients, implying effective anti-emetic use.
Objective: To analyze anti-emetic effect of sub-hypnotic dose of Propofol in patients undergoing cesarean section. Study Design and Setting: Prospective, Interventional Randomized Clinical trial done at PAF Hospital Islamabad, from 1stAugust 2021 to 31stJanuary 2022. Methodology: A total of 60 patients undergoing elective cesarean under spinal anesthesia were selected for the study. Selected patients were randomly allocated either of the two groups. Patients included in the Group A received sub hypnotic intravenous dose of Propofol as per their body weight, whereas the Group B patients received intravenous saline (0.9%). Postoperative nausea and vomiting was assessed during patients’ PACU stay of 1 hour using the subjective feelings of the patients. If the patient complains of vomiting in PACU, an intravenous dose of 10mg Metoclopramide was given as rescue antiemetic. Results: Mean age of patients was 30.73±4.51 years. APFEL score 3 was observed in 15 (50.0%) in group A and 15 (50.0%) in group B. Score 4 was observed in 4 (13.3%) in group A and 08 (26.7%) in group B( p-value 0.33).Vomiting was observed in 06 (20.0%) in group A and 24 (80.0%) in group B respectively( p-value of <0.01).Nausea was found in 08 (26.7%) in group A and 25 (83.3%) in group B (p-value <0.01). Conclusion: Propofol in sub-hypnotic dose is effective in the prevention of postoperative nausea and vomiting in patients undergoing cesarean section under spinal anesthesia.
No takes yet. Share an insight, caveat, or question.
Nazir et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: